A significant discovery in cancer study is emerging with the use of nanobodies to re-engage dysfunctional p53. This essential tumor suppressor protein is frequently disabled in several types of malignancies, causing https://bookmarklinx.com/story22009685/nanobodies-revive-tumor-suppressor-p53-new-new-approach-for-cancer-management